Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.
Ontology highlight
ABSTRACT: Dengue virus (DENV) infects 400 million people worldwide annually. Infection of more than one serotype of DENV highly corresponds to dengue hemorrhagic fever and dengue shock syndrome, which are the leading causes of high mortality. Due to lack of effective vaccines and unavailable therapies against DENV, discovery of anti-DENV agents is urgently needed. We first characterize that Schisandrin A can inhibit the replication of four serotypes of DENV in a concentration- and time-dependent manner, with an effective half-maximal effective concentration 50% (EC50) value of 28.1 ± 0.42 μM against DENV serotype type 2 without significant cytotoxicity. Furthermore, schisandrin A can effectively protect mice from DENV infection by reducing disease symptoms and mortality of DENV-infected m
SUBMITTER: Yu JS
PROVIDER: S-EPMC5364541 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA